# Vision And Product System

BellLabs is an agentic application system for biotech, biohacking, and longevity exploration. It should feel like the missing platform between GitHub, Robinhood, Figma, PubMed, consumer lab testing, quantified self tooling, and agentic commerce.

Software has GitHub because implementations can be shared, forked, inspected, and reused. Investing has Robinhood because complex financial primitives were packaged into accessible workflows. Design has Figma because professional design artifacts became collaborative, inspectable, and composable. Health and longevity do not yet have the equivalent because biology is harder, the stakes are higher, evidence is messier, customization requires specimens and measurements, trust is fragile, and the line between education and medical advice must be carefully maintained.

BellLabs exists because the social and technical conditions have changed. People are already buying their own lab tests, reading case studies, comparing supplements, using red light and sound devices, tracking wearables, following longevity practitioners, and asking AI systems to help them reason. BellLabs should give that behavior a serious, structured, evidence-aware home.

## Product Thesis

The next shopping paradigm is not a cart with recommendations. It is an agentic decision trail.

When a user considers a biomarker panel, supplement, wearable, treatment, device, food product, or practitioner protocol, the platform should attach a living evidence record to that decision. The record should include:

- What the user was trying to learn or improve.
- Which sources, practitioners, products, claims, and mechanisms were examined.
- Which pieces of evidence supported or weakened the decision.
- Which uncertainties, contraindications, adverse effects, and missing measurements remain.
- How the decision connects to the user's existing protocol, goals, biomarkers, budget, and timeline.
- Which follow-up actions are required after purchase or completion.

In BellLabs, the research and investigation of the user are integral parts of the purchase.

## Core User Adventure

A user might discover Bryan Johnson, inspect his public protocol, find TruDiagnostic as a lab testing provider, compare that test to other epigenetic clock or biomarker panel options, and decide to order a panel. BellLabs should help the user understand why the test matters, how it connects to their goals, what it can and cannot conclude, and what decisions it may unlock.

The platform should then continue past checkout. It should remember that the user is waiting for the test. It should allow the user to say, "I completed the draw," "my report arrived," or "the company asked me for another specimen." The agent should update the lifecycle state, ingest the report, extract biomarkers, map them to reference ranges and prior measurements, and help assemble a dashboard view.

The same pattern applies to devices, treatments, supplements, lifestyle protocols, and exploratory research campaigns.

## Platform Pillars

### 1. Biotech Knowledge Graph

The existing `biotech-kg` schema already points in the right direction. It models organizations, products, compounds, lab tests, biomarkers, mechanisms, protocols, studies, claims, documents, episodes, listings, adverse effects, safety signals, manufacturing processes, regulatory pathways, and more.

This graph should become the platform's shared world model. It should answer questions like:

- Which companies sell a product or service relevant to this goal?
- Which claims are attached to this product, and where did those claims appear?
- Which biomarkers, mechanisms, pathways, and studies are connected to an intervention?
- Which public practitioner protocols include this product, device, lab test, or lifestyle behavior?
- Which safety signals or contraindications are nearby?
- Which entities are well-covered by evidence and which are mostly marketing narrative?

### 2. Personal Health Graph

The shared biotech graph must be separated from the user's private graph. The personal graph should represent:

- Goals, constraints, preferences, budget, risk tolerance, and medical boundaries.
- Biomarkers, lab reports, specimen metadata, reference ranges, and trends.
- Wearable streams, subjective observations, symptoms, side effects, and adherence.
- Protocols, protocol steps, adjustments, outcomes, and abandoned experiments.
- Product decisions, purchase states, agentic cart items, and follow-up tasks.
- Private notes, uploaded files, consent settings, and clinician involvement.

The system should never collapse public evidence into personal conclusions without provenance and confidence. BellLabs should help users reason, not pretend that a sparse personal model is a diagnosis engine.

### 3. Agentic Exploration

Users should be able to move fluidly from casual browsing to deep investigation.

Exploration surfaces should include:

- Entity pages for products, treatments, practitioners, companies, lab tests, biomarkers, mechanisms, studies, and protocols.
- Guided comparison views for similar products or testing options.
- Evidence maps that show claims, sources, conflicts, and confidence.
- "Start a research campaign" buttons from any entity, claim, product, protocol, or question.
- Saved explorations that can become protocol candidates, purchases, dashboards, or public guides.

### 4. Protocol Studio

Biohacking often resembles software development. A user defines a desired outcome, chooses interventions, runs a time-boxed experiment, measures changes, adjusts, and repeats.

Protocol Studio should support:

- Protocol templates, forks, versions, and changelogs.
- Goals, hypotheses, inclusion and exclusion criteria, and stop conditions.
- Intervention steps with dose, schedule, product, device, lifestyle, or lab components.
- Measurement plans with biomarkers, wearable metrics, subjective check-ins, and cadence.
- Review checkpoints and agent-generated retrospectives.
- Community sharing with safety warnings, evidence links, and personal context redaction.

### 5. Agentic Cart And Decision Ledger

Purchases should be represented as decisions, not just transactions. BellLabs may not always be able to complete checkout directly because many companies will lack APIs, agentic commerce endpoints, or global carts. The platform should still track the decision, link to the external checkout, and preserve the reasoning bundle.

Every cart item should be able to point to:

- The research notes that supported the decision.
- The evidence graph and source documents.
- The user goal or protocol step it serves.
- The expected timeline and follow-up tasks.
- The completion state, report upload state, and outcome review.

### 6. Algorithm And Analytics Marketplace

BellLabs should eventually procure, license, integrate, or develop high-quality algorithms for interpreting user data. These may include biological age models, lab panel summarizers, microbiome interpretation layers, wearable-derived recovery or sleep scoring, risk models, protocol adherence analytics, and multi-modal dashboards.

The marketplace should distinguish:

- Educational summaries.
- Exploratory personal analytics.
- Clinically validated tools.
- Medical-device-regulated tools, if any are ever included.

Trust depends on making these boundaries visible.

### 7. Community Knowledge And Guides

BellLabs should contain high-quality system and user content: guides, protocol templates, product explainers, integration recipes, dashboards, and research missions. A guide for an EWOT oxygen machine might include buying considerations, daily use patterns, safety caveats, maintenance, studies, subjective reports, and wearable integration instructions.

The strongest version is a biological GitHub: humans share protocols and systems, agents inspect and improve them, evidence is linked, and paid products or services can be attached without hiding the incentives.

### 8. ME2 Personal Model

The ME2 model is the north star: a progressively richer digital representation of the user. The first useful version is not molecular simulation. It is a well-indexed, provenance-rich, personalized model of goals, labs, interventions, outcomes, documents, and uncertainty.

ME2 should mature in phases:

- Memory: durable personal health context and decision history.
- Measurement: normalized biomarkers, wearable streams, reports, and observations.
- Mechanism: links from personal interventions to biological mechanisms and evidence.
- Forecasting: cautious scenario analysis based on population data, prior personal response, and known uncertainty.
- Simulation: limited domain-specific models where scientifically justified.

## Trust, Safety, And Boundary Design

BellLabs should be explicit that it provides educational exploration, evidence organization, protocol planning support, and decision provenance. It should not diagnose, prescribe, or imply that agent outputs replace a clinician.

The product should include:

- Medical boundary language at points of interpretation and purchase.
- Safety and contraindication checks before protocol activation.
- Clear confidence and evidence strength labels.
- Source provenance for claims and recommendations.
- Escalation prompts for clinician review when risk is high.
- Red-team evaluations for unsafe advice, overclaiming, and missing uncertainty.

The goal is not to make the system timid. The goal is to make ambition survivable.
